Pandu Kulkarni

Dr. Pandu Kulkarni is the Chief Analytics Officer and Vice President of Biometrics and Advanced Analytics at Eli Lilly and Co. Dr. Kulkarni leads a division of nearly 600 people composed of statisticians from discovery to commercialization, advanced analytics, data management, data standards and technology. He joined Eli Lilly in 2000 and has held numerous leadership positions, including technical and management positions within, and outside of, statistics.

Dr. Kulkarni received several grants from the US Air Force to develop techniques that evaluate and study the effects of environmental contaminants, such as dioxin on humans. He also received grants from NASA to study the effects of microgravity to see the effectiveness of exercise countermeasures in minimizing the effects of microgravity on astronauts.

A tenured professor at the University of South Alabama, Dr. Kulkarni has given numerous invited presentations across the globe to provide training, continuing medical education, and workshops on the use of statistics in medical research and has published over 50 articles in statistics and medical areas in peer-reviewed journals.

He earned his Ph.D. in Statistics at LaTrobe University in Melbourne, Australia.